Science then & now: Progress that you can see
Click and drag to compare and contrast archive photos from the lab with current-day images of research at Boston Children’s Hospital. Then, 1986: Stuart H. Orkin, MD, examines the DNA sequence of a gene. Now, 2017: Today, Orkin is associate chief of Hematology/Oncology and chairman of Pediatric Oncology at Dana-Farber/Boston Children’s Cancer and Blood Disorders Center...
The post Science then & now: Progress that you can see appeared first on Vector.
Angiogenesis: The slow growth of a science
Sometimes a scientific idea takes a long time to make its way forward. Angiogenesis is a case in point. As surgeon-in-chief at Boston Children’s Hospital, Judah Folkman, MD, noted that malignant tumors often had a bloody appearance. In The New England Journal of Medicine in 1971, he hypothesized that tumors cannot grow beyond a certain...
The post Angiogenesis: The slow growth of a science appeared first on Vector.
Who We are
The mission of the Technology and Innovation Development Office (TIDO) to maximize the impact of Boston Children’s innovations on patient health while enhancing the research endeavor.
News and Events
Register for Boston Children’s Rare Disease Networking Event - May 25
TIDO, the Manton Center, and MassBio will co-host a Boston Children’s Rare Disease Networking Event on May 25th from 4:30 – 7:00 pm at MassBio Headquarters in Cambridge. This event will showcase Children’s research in rare diseases and discuss advancing new therapy development through industry-academic collaborations. The program will include an academic-industry panel featuring our CSO David Williams, MD, Manton Center Director Alan Beggs, PhD, Philip Reilly, MD, JD, of Third Rock Ventures, and Alvin Shih, MD, of Enzyvant. In addition, there will be short research talks by Boston Children’s researchers and networking sessions with posters.
Register to attend by clicking the above title.
Download TIDO's new Inventor's Guide
TIDO is proud to announce the release of our new Inventor’s Guide. The booklet details the commercialization process at Boston Children’s, how to work with TIDO to give your invention the best possibility for success, and answers to frequently asked questions we encounter.
Updated Material Transfer Agreement (MTA) Procedures (Click here)
The new IP Policy allows for researchers to independently generate and complete certain outbound academic MTAs if specific criteria are met. In addition, we have implemented a new form for initiating inbound MTAs. Please click the link above for instructions and to download the forms.